Both are still in trials but 10 months with chemotherapy versus 2.4 months could bring the drug to the front view of the public, as has been done in the past with activists groups pushing for approval of other drugs. Both are different with treatment plans and the drugs would be limited to the...
Posted to
The Medical Quack .... by Barbara Duck
on 12-04-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, Cancer, clinical trials, Prostate Cancer, PSA, R and D, antigen, testosterone
Other countries outside the US are also expressing and formulating their clinical trial business in India. Of late there have been a multitude of these reportings, it doesn’t appear India will be lacking in the R and D trial business any time soon. BD The operation will be run by the...
Nothing new here in what has been posted, but this time the predictions are coming from within Ernst and Young from India. BD The Indian clinical trials market is predicted to continue its growth despite the current financial climate, according to a partner at Ernst & Young India’s Healthsciences...
Posted to
The Medical Quack .... by Barbara Duck
on 11-25-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, clinical trials, R and D, India, Economics, Outsourcing, Employment, Clinic
The post is a summary of how things look today and under related reading I have included some past posts that may offer a few more details on how the shift it taking place today. Things are also happening and humming as well in China and you can search and find some recent relative posts here as...
Posted to
The Medical Quack .... by Barbara Duck
on 11-20-2008
Filed under: Pharma/FDA News, My Commentaries, healthcare, Pharma, clinical trials, R and D, India, Economics, Mayo Clinic, Outsourcing, Employment, China pharma
The trial is for women who have the HER2 gene and have already received treatments, details listed below. BD The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an...
This also means some folks will be losing jobs as well. The unit has been in place since 1991 and has provided information on over 1,000 trials. This is just one more sign of how the face of the pharmaceutical business is changing. It is about one fifth the cost to run trials in countries...
Posted to
The Medical Quack .... by Barbara Duck
on 11-10-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, clinical trials, India, Economics, Mayo Clinic, Outsourcing, China pharma
Great effort on the members of Congress to “ask”, but the end result is what counts. R and D with major pharmaceutical companies is presently in the business of moving overseas to India and China, as well as some clinical trials, so the impact of the request from the members of Congress may or...
Posted to
The Medical Quack .... by Barbara Duck
on 11-04-2008
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, clinical trials, Pfizer, China, R and D, India, Outsourcing